| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Predicted |
|---|
| Creation Date | 2021-09-18 00:59:02 UTC |
|---|
| Update Date | 2022-11-30 20:09:01 UTC |
|---|
| HMDB ID | HMDB0294403 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | DG(10:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) |
|---|
| Description | DG(10:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the class of organic compounds known as hepoxilins. These are eicosanoids containing an oxirane group attached to the fatty acyl chain. Based on a literature review very few articles have been published on DG(10:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)). |
|---|
| Structure | CCCCCCCCCC(=O)OC[C@@H](O)COC(=O)CCC\C=C/C\C=C/CC1OC1C\C=C/CCCCC InChI=1S/C33H56O6/c1-3-5-7-9-12-17-21-25-32(35)37-27-29(34)28-38-33(36)26-22-18-14-11-13-16-20-24-31-30(39-31)23-19-15-10-8-6-4-2/h11,14-16,19-20,29-31,34H,3-10,12-13,17-18,21-28H2,1-2H3/b14-11-,19-15-,20-16-/t29-,30?,31?/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (2R)-3-(Decanoyloxy)-2-hydroxypropyl (5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoic acid | HMDB |
|
|---|
| Chemical Formula | C33H56O6 |
|---|
| Average Molecular Weight | 548.805 |
|---|
| Monoisotopic Molecular Weight | 548.407689523 |
|---|
| IUPAC Name | (2R)-3-(decanoyloxy)-2-hydroxypropyl (5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoate |
|---|
| Traditional Name | (2R)-3-(decanoyloxy)-2-hydroxypropyl (5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoate |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCCCCCCCCC(=O)OC[C@@H](O)COC(=O)CCC\C=C/C\C=C/CC1OC1C\C=C/CCCCC |
|---|
| InChI Identifier | InChI=1S/C33H56O6/c1-3-5-7-9-12-17-21-25-32(35)37-27-29(34)28-38-33(36)26-22-18-14-11-13-16-20-24-31-30(39-31)23-19-15-10-8-6-4-2/h11,14-16,19-20,29-31,34H,3-10,12-13,17-18,21-28H2,1-2H3/b14-11-,19-15-,20-16-/t29-,30?,31?/m1/s1 |
|---|
| InChI Key | MZUPYIQUEVCZPZ-YFMBPVJYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as hepoxilins. These are eicosanoids containing an oxirane group attached to the fatty acyl chain. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Fatty Acyls |
|---|
| Sub Class | Eicosanoids |
|---|
| Direct Parent | Hepoxilins |
|---|
| Alternative Parents | |
|---|
| Substituents | - Hepoxilin
- Diradylglycerol
- Diacylglycerol
- 1,3-acyl-sn-glycerol
- Glycerolipid
- Fatty acid ester
- Dicarboxylic acid or derivatives
- Secondary alcohol
- Carboxylic acid ester
- Oxacycle
- Organoheterocyclic compound
- Ether
- Oxirane
- Dialkyl ether
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Alcohol
- Aliphatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aliphatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 8.43 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 31.5507 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 0.69 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 4633.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 637.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 316.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 307.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 938.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1576.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1002.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 129.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 3040.9 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 963.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2702.3 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1120.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 685.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 499.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 697.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.7 seconds | 40023050 |
Predicted Kovats Retention IndicesNot Available |
|---|